Breast cancer survival and tumor characteristics of premenopausal women carrying the CHEK2*1100delC mutation

被引：0
|
作者：
Schmidt, M. K.
Tollenaar, R. A. E. M.
De Kemp, S.
Broeks, A.
Cornelisse, C. J.
Smit, V. T. H. B. M.
Van der plas, A.
De groot, R.
Peterse, J. L.
Van 't Veer, L. J.
Van Leeuwen, F. E.
机构：
[1] Netherlands Canc Inst, Amsterdam, Netherlands
[2] Leiden Univ, Ctr Med, Leiden, Netherlands
来源：
EUROPEAN JOURNAL OF EPIDEMIOLOGY | 2006年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
314
引用
收藏
页码：107 / 107
页数：1
相关论文
共 50 条
  • [21] The CHEK2 1100delC mutation identifies families with a hereditary breast and colorectal cancer phenotype
    Meijers-Heijboer, H
    Wijnen, J
    Vasen, H
    Wasielewski, M
    Wagner, A
    Hollestelle, A
    Elstrodt, F
    van den Bos, R
    de Snoo, A
    Fat, GTA
    Brekelmans, C
    Jagmohan, S
    Franken, P
    Verkuijlen, P
    van den Ouweland, A
    Chapman, P
    Tops, C
    Möslein, G
    Burn, J
    Lynch, H
    Klijn, J
    Fodde, R
    Schutte, M
    AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 72 (05) : 1308 - 1314
  • [22] Absence of CHEK2*1100delC mutation in families with hereditary breast cancer in North America
    Iniesta, Maria D.
    Gorin, Michael A.
    Chien, Ling-Chen
    Thomas, Samantha M.
    Milliron, Kara J.
    Douglas, Julie A.
    Merajver, Sofia D.
    CANCER GENETICS AND CYTOGENETICS, 2010, 202 (02) : 136 - 140
  • [23] A multicenter study of cancer incidence in CHEK2 1100delC mutation carriers
    Thompson, Deborah
    Seal, Sheila
    Schutte, Mieke
    McGuffog, Lesley
    Barfoot, Rita
    Renwick, Anthony
    Eeles, Rosalind
    Sodha, Nayanta
    Houlston, Richard
    Shanley, Susan
    Klijn, Jan
    Wasielewski, Marijke
    Chang-Claude, Jenny
    Futreal, P. Andrew
    Weber, Barbara L.
    Nathanson, Katherine L.
    Stratton, Michael
    Meijers-Heijboer, Hanne
    Rahman, Nazneen
    Easton, Douglas F.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2006, 15 (12) : 2542 - 2545
  • [24] Frequency of the CHEK2 1100delC mutation among women with early-onset and bilateral breast cancer
    Dapeng Ding
    Ying Zhang
    Xiaofeng He
    Wei Meng
    Wenli Ma
    Wenling Zheng
    Breast Cancer Research, 14
  • [25] Excess Risk for Contralateral Breast Cancer in CHEK2*1100delC Germline Mutation Carriers
    Annegien Broeks
    Lot de Witte
    Anke Nooijen
    Angelina Huseinovic
    Jan G.M. Klijn
    Flora E. van Leeuwen
    Nicola S. Russell
    Laura J. van't Veer
    Breast Cancer Research and Treatment, 2004, 83 : 91 - 93
  • [26] The CHEK2*1100delC mutation predisposes for early onset breast cancer in breast cancer families.
    Van Binst, T
    Goelen, G
    Sermijn, E
    Van Hassel, G
    De Neef, K
    Bonduelle, M
    Fontaine, C
    Teugels, E
    De Greve, JJ
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S151 - S151
  • [27] CHEK2* 1100delC screening of Asian women with a family history of breast cancer is unwarranted
    Lee, Ann S. G.
    Ang, Peter
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (14) : 2419 - 2419
  • [28] Sensitivity to systemic therapy for metastatic breast cancer in CHEK2 1100delC mutation carriers
    Kriege, Mieke
    Jager, Agnes
    Hollestelle, Antoinette
    Berns, Els M. J. J.
    Blom, Jannet
    Meijer-van Gelder, Marion E.
    Sieuwerts, Anieta M.
    van den Ouweland, Ans
    Collee, J. Margriet
    Kroep, Judith R.
    Martens, John W. M.
    Hooning, Maartje J.
    Seynaeve, Caroline
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2015, 141 (10) : 1879 - 1887
  • [29] Excess risk for contralateral breast cancer in CHEK2*1100delC germline mutation carriers
    Broeks, A
    de Witte, L
    Nooijen, A
    Huseinovic, A
    Klijn, JGM
    van Leeuwen, FE
    Russell, NS
    van't Veer, LJ
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 83 (01) : 91 - 93
  • [30] Does breast cancer associated with CHEK2 1100delC carry characteristics of basal phenotype?
    Dede, Didem S.
    Sari, Ebru
    Bulut, Nilufer
    Altundag, Kadri
    BREAST CANCER RESEARCH AND TREATMENT, 2007, 103 (03) : 371 - 371
12345